A large-scale analysis of targeted metabolomics data from heterogeneous biological samples provides insights into metabolite dynamics
Open Access
- 9 July 2019
- journal article
- research article
- Published by Springer Nature in Metabolomics
- Vol. 15 (7) , 1-13
Abstract
Introduction We previously developed a tandem mass spectrometry-based label-free targeted metabolomics analysis framework coupled to two distinct chromatographic methods, reversed-phase liquid chromatography (RPLC) and hydrophilic interaction liquid chromatography (HILIC), with dynamic multiple reaction monitoring (dMRM) for simultaneous detection of over 200 metabolites to study core metabolic pathways. Objectives We aim to analyze a large-scale heterogeneous data compendium generated from our LC–MS/MS platform with both RPLC and HILIC methods to systematically assess measurement quality in biological replicate groups and to investigate metabolite abundance changes and patterns across different biological conditions. Methods Our metabolomics framework was applied in a wide range of experimental systems including cancer cell lines, tumors, extracellular media, primary cells, immune cells, organoids, organs (e.g. pancreata), tissues, and sera from human and mice. We also developed computational and statistical analysis pipelines, which include hierarchical clustering, replicate-group CV analysis, correlation analysis, and case–control paired analysis. Results We generated a compendium of 42 heterogeneous deidentified datasets with 635 samples using both RPLC and HILIC methods. There exist metabolite signatures that correspond to various phenotypes of the heterogeneous datasets, involved in several metabolic pathways. The RPLC method shows overall better reproducibility than the HILIC method for most metabolites including polar amino acids. Correlation analysis reveals high confidence metabolites irrespective of experimental systems such as methionine, phenylalanine, and taurine. We also identify homocystine, reduced glutathione, and phosphoenolpyruvic acid as highly dynamic metabolites across all case–control paired samples. Conclusions Our study is expected to serve as a resource and a reference point for a systematic analysis of label-free LC–MS/MS targeted metabolomics data in both RPLC and HILIC methods with dMRM.Keywords
All Related Versions
Funding Information
- U.S. Department of Education
- American Association for Cancer Research (13-70-25-LYSS, 17-20-01-LYSS)
- Damon Runyon Cancer Research Foundation (DFS-09-14)
- V Foundation for Cancer Research (V2016-009)
- Sidney Kimmel Foundation for Cancer Research (SKF-16-005)
- National Cancer Institute (P30 CA046592)
- National Institutes of Health (DK097153)
- Charles Woodson Research Fund
- University of Michigan Pediatric Brain Tumor Initiative
This publication has 26 references indexed in Scilit:
- Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic CancerCell Metabolism, 2019
- MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysisNucleic Acids Research, 2018
- SECIMTools: a suite of metabolomics data analysis toolsBMC Bioinformatics, 2018
- Metabolomics: beyond biomarkers and towards mechanismsNature Reviews Molecular Cell Biology, 2016
- Toward ‘Omic Scale Metabolite Profiling: A Dual Separation–Mass Spectrometry Approach for Coverage of Lipid and Central Carbon MetabolismAnalytical Chemistry, 2013
- A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transferaseClinical Chemistry and Laboratory Medicine (CCLM), 2013
- Hydrophilic interaction liquid chromatography (HILIC)—a powerful separation techniqueAnalytical and Bioanalytical Chemistry, 2011
- Targeted Metabolomics for Biomarker DiscoveryAngewandte Chemie International Edition, 2010
- Metabolomic applications of HILIC–LC–MSMass Spectrometry Reviews, 2009
- Impact of column temperature and mobile phase components on selectivity of hydrophilic interaction chromatography (HILIC)Journal of Separation Science, 2008